High-dimensional immunoprofiling for biologics and complex vaccines

Prof. Jeremy Derrick
Co-Founder

Jeremy obtained his first degree and PhD from the University of Cambridge. He was appointed a Lecturer at UMIST in Manchester in 1993 and was a Lister Institute Fellow from 1996 to 2001. He joined the University of Manchester in 2003, when the two universities merged. He has worked extensively on protein structure and function, publishing more than 130 peer-reviewed papers. He has served on multiple grant panels, and is continually requested to act as a reviewer for major scientific journals. More recently, he has applied his extensive experience of working with the commercial sector to the development of vaccines and formulation of biopharmaceutical drugs.

• LinkedIn
• Email
• ORCID

Dr Fidel Ramirez Bencomo
Co-founder

Fidel graduated in Biochemistry and Molecular Biology from the University of Havana and earned a PhD in Microbiology from the University of Manchester. With over 10 years’ experience, he specialises in monoclonal antibody production, diagnostic assay development, and protein microarrays. Fidel’s work at the Finlay Vaccine Institute (Cuba) and in the University of Manchester focuses on immunoprofiling, epitope mapping, and vaccine development. He has led projects supported by GSK and the Bill and Melinda Gates Foundation, and has presented at major conferences and published numerous peer-reviewed papers.

• LinkedIn
• Email
• ORCID